(2) Based on a Schedule 13-G filed with the SEC on November 8, 2024, Blackrock Inc. has sole voting power over 18,460,443 shares of our common stock and sole dispositive power over 18,614,758 shares of our common stock. The principal business office of BlackRock, Inc. is 50 Hudson Yards, New York, New York 10001.
(3) Consists of (i) 1,343,454 shares of common stock, 7,191 shares of common stock issuable pursuant to warrants exercisable within 60 days of April 14, 2025 and 5,692,043 shares of common stock issuable pursuant to stock options exercisable within 60 days of April 14, 2025 held by Dr. Musunuri; and (ii) 1,145,299 shares of common stock and 405 shares of common stock issuable pursuant to warrants exercisable within 60 days of April 14, 2025, in each case held by KVM Holdings, LLC. Dr. Musunuri is a member and officer of KVM Holdings, LLC and has voting and investment power over the shares held by KVM Holding, LLC.
(4) Consists of 214,495 shares of common stock and 863,708 shares of common stock issuable pursuant to stock options exercisable within 60 days of April 14, 2025, held by Dr. Upadhyay.
(5) Consists of 4,436 shares of common stock and 102,822 shares of common stock issuable pursuant to stock options exercisable within 60 days of April 14, 2025, held by Dr. Qamar.
(6) Consists of (i) 360,631 shares of common stock issuable pursuant to stock options exercisable within 60 days of April 14, 2025, held by Dr. Zhang and (ii) 1,165,299 shares of common stock held by Gupiao Trust. Dr. Zhang is the beneficiary of Gupiao Trust has voting and investment power over securities held by Gupiao Trust.
(7) Consists of (i) 550,674 shares of common stock, 354 shares of common stock issuable pursuant to warrants exercisable within 60 days of April 14, 2025, and 408,631 shares of common stock issuable pursuant to stock options exercisable within 60 days of April 14, 2025, held by Dr. Kompella; and (ii) 154,416 shares of common stock held by Kompella LLC. Dr. Kompella has voting and investment power over the shares of common stock held by Kompella LLC.
(8) Consists of 75,000 shares of common stock and 406,631 shares of common stock issuable pursuant to stock options exercisable within 60 days of April 14, 2025, held by Ms. Castillo.
(9) Consists of 10,000 shares of common stock and 415,131 shares of common stock issuable pursuant to stock options exercisable within 60 days of April 14, 2025, held by Dr. Fernandes.
(10) Consists of (i) 358,679 shares of common stock issuable pursuant to stock options exercisable within 60 days of April 14, 2025, held by Dr. Whittington; and (ii) 1,000 shares of common stock held by Marna C. Whittington Revocable Trust. Dr. Whittington is the trustee and sole beneficiary of the Marna C. Whittington Revocable Trust.
(11) Blaise Coleman has been nominated by the Board for election as a director at the Annual Meeting.
(12) Satish Chandran, Ph.D. has been nominated by the Board for election as a director at the Annual Meeting.
(13) Consists of 4,665,873 shares of common stock, 7,950 shares of common stock issuable pursuant to warrants exercisable within 60 days of April 14, 2025, and 8,608,276 shares of common stock issuable pursuant to stock options exercisable within 60 days of April 14, 2025. Of these amounts, 1,800 shares of common stock are held by an executive officer who was not an NEO as of April 14, 2025.
